An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML.
Bullinger L, Döhner K, Kranz R, Stirner C, Fröhling S, Scholl C, Kim YH, Schlenk RF, Tibshirani R, Döhner H, Pollack JR.
Bullinger L, et al. Among authors: scholl c.
Blood. 2008 May 1;111(9):4490-5. doi: 10.1182/blood-2007-09-115055. Epub 2008 Feb 28.
Blood. 2008.
PMID: 18309032
Free article.